Cayce Denton - Director @ Temasek Holdings

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Glympse Bio	Temasek Holdings	—	Series B - Glympse Bio	obfuscated obfuscation
obfuscated obfuscation	Trevi Therapeutics	TPG Biotech	—	Series C - Trevi Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Trevi Therapeutics	TPG Biotech	No	Series C - Trevi Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Trevi Therapeutics	TPG Biotech	Yes	Series B - Trevi Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Otonomy	TPG Biotech	No	Series D - Otonomy	obfuscated obfuscation
obfuscated obfuscation	Otonomy	TPG Biotech	No	Series C - Otonomy	obfuscated obfuscation
obfuscated obfuscation	Veracyte	TPG Biotech	No	Series C - Veracyte	obfuscated obfuscation
obfuscated obfuscation	Trevi Therapeutics	TPG Biotech	Yes	Series A - Trevi Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Otonomy	TPG Biotech	—	Series B - Otonomy	obfuscated obfuscation
obfuscated obfuscation	Veracyte	TPG Biotech	No	Series B - Veracyte	obfuscated obfuscation

Number of Current Jobs

Number of Past Jobs

is the

Director

. Additionally,

has had

past jobs including

Associate

Organization Name	Title At Company	Start Date	End Date
TPG Biotech	Associate	May 2010	Dec 2016
Genentech	Finance Manager	Aug 2009	Apr 2010
Novartis	Business Development Analyst	2004	2005
Atlas Venture	analyst	Aug 2002	May 2004
Credit Suisse First Boston	Investment Banker	—	—
PatientSafe Solutions	Vice President, TPG Biotech	—	—

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

is the

Board member

Organization Name	Title At Company	Start Date	End Date
Trevi Therapeutics	Board Member	Dec 2012	Dec 2017
Veracyte	Board of Observer	—	—
PatientSafe Solutions	Board of Directors	—	—
Otonomy	Board Member	—	—
Karos Pharmaceuticals	Board of Directors	—	—
Glympse Bio	Board Observer	Jul 2020	—

Hub Name	CB Rank (Hub)
Impact Investing Companies With More Than 50 Employees	26,266
Private Equity Firms with Investments in San Francisco, California	9,936
Secondary Market Investors with Investments in San Francisco, California	56,720
Impact Investing Companies With More Than $10M in Revenue	30,612
Impact Investing Companies With More Than $100M in Revenue	99,171
Private Equity Stage Investors with Investments in San Francisco, California	12,304
Secondary Market Investors with Investments in California	47,285
Angel Investment Companies With More Than 10 Employees	24,644
Life Science Companies With More Than $100M in Revenue	99,681
Secondary Market Investors with Investments in Western US	49,235